Chiron Capital Management’s Trulieve Cannabis Corp TRLV Stock Holding History

Chiron Capital Management’s Portfolio TRLV Stock Details TRLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Buy	+22,965	New	+$221K	0.2%	121

Other funds holding TRLV

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

ING Group Amsterdam, Netherlands $20.5B AUM 49.71% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

IGAM

iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Chiron Capital Management's TRLV Position: Q2 2026 in Review

Chiron Capital Management opened a new position in Trulieve Cannabis Corp (TRLV) in Q2 2026: 22,965 shares worth $226K. The stake represents 0.2% of the portfolio and ranks #121 among its holdings.

125 funds tracked by Wall St. Rank hold TRLV as of Q2 2026.

Chiron Capital Management held 22,965 shares of Trulieve Cannabis Corp worth $226K as of Q2 2026.
Trulieve Cannabis Corp was a new Chiron Capital Management position in Q2 2026.
Trulieve Cannabis Corp made up 0.2% of Chiron Capital Management's portfolio in Q2 2026, its #121 holding.
125 funds tracked by Wall St. Rank held Trulieve Cannabis Corp as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.